Meiji Holdings Co., Ltd. has confirmed the disposal of 19,100 shares of treasury stock under a restricted stock incentive plan for employees in managerial positions.
The board approved the Meiji Holdings Treasury Stock Disposal on July 4, 2025. The move applies to staff at Meiji Holdings and its subsidiaries Meiji Co., Ltd., Meiji Seika Pharma Co., Ltd., and KM Biologics Co., Ltd.
The date of payment is scheduled for September 25, 2025. Each of 191 qualified employees will receive 100 shares, which cost JPY 3,186 per share. The total settlement price JPY is 60,852,600.
This incentive scheme was originally introduced on January 10, 2023. This supports the medium and long -term commercial goals of the Meiji group, which by connecting employee performance to a shareholder value.
The allocation will be handled as in-kind contributions using monetary claims issued by the business subsidiaries. The scheme includes a transfer restriction period of two years, ending on September 24, 2027.
Employees who maintain their position during this period will be prohibited. There are also conditions for special cases such as death, promotion or international transfer. In other scenarios, shares will be returned to the company at no cost.
The settlement price was based on the final share price which ends July 3, 2025. Meji Holdings said that pricing shows no significant benefit or bias.
The MEI Holdings Treasury stock aims to coordinate employees’ interests with business development and price construction.
